The Rapid Test Ag 2019-nCoV (Self-Test) has been granted a special authorization from the National Organization for Medicines (EOF) for use in Greece, with Ref No: 33853/ 09-04-2021.

The Rapid Ag Self-Test of ProGnosis Biotech is a simple, accurate, and easy-to-use method using a minimally invasive nasal swab. The test shows high sensitivity and specificity and is confirmed to detect also the new dominant variants of SARS-CoV-2, known as the UK (B.1.1.7), South African (B.1.351) and Brazilian (P.1) variants.